Levofloxacin Noridem Enterprises (Levofloxacin)

Levofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for DNA replication and transcription. This inhibition prevents bacterial DNA from unwinding and resealing, leading to the cessation of bacterial growth and ultimately bacterial cell death.

The specific dose and duration of levofloxacin therapy are determined by the prescribing clinician based on the infection type, severity, patient renal function, and other clinical factors. Healthcare professionals should follow local guidelines and product labeling when selecting the appropriate regimen.

Levofloxacin’s pregnancy safety category is unknown, and it is generally avoided during pregnancy unless the potential benefit justifies the risk. Limited data are available for breastfeeding; therefore, the drug should be used with caution, and a healthcare provider should assess the risk‑benefit ratio for mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Levofloxacin is a third‑generation fluoroquinolone with enhanced activity against Gram‑negative organisms and improved pharmacokinetics compared with older agents like ciprofloxacin. It offers once‑daily dosing for many indications, but shares class‑related risks such as tendon toxicity and QT prolongation, which must be weighed against therapeutic benefits.

Levofloxacin Noridem Enterprises should be stored at ambient temperature, below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct light, and ensure the container is tightly sealed when not in use.

Levofloxacin Noridem Enterprises is supplied as an intravenous solution. It is administered by slow infusion into a vein, typically over 30–60 minutes, under the supervision of qualified healthcare personnel. The exact infusion rate and duration are determined by the prescriber.

Serious risks include tendon rupture (especially Achilles), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, peripheral neuropathy, and hepatic dysfunction. Patients should be monitored closely for any of these events.

Levofloxacin is contraindicated in patients with a known hypersensitivity to fluoroquinolones. It should be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, those with significant QT prolongation, and patients for whom safer alternative antibiotics are available, especially in pregnancy or lactation unless absolutely necessary.